<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1129" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1129/" /><meta name="ncbi_pagename" content="Long QT Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Long QT Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Long QT Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/02/08" /><meta name="citation_author" content="Mariëlle Alders" /><meta name="citation_author" content="Hennie Bikker" /><meta name="citation_author" content="Imke Christiaans" /><meta name="citation_pmid" content="20301308" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1129/" /><meta name="citation_keywords" content="A-kinase anchor protein 9" /><meta name="citation_keywords" content="Alpha-1-syntrophin" /><meta name="citation_keywords" content="Ankyrin-2" /><meta name="citation_keywords" content="Calmodulin" /><meta name="citation_keywords" content="Caveolin-3" /><meta name="citation_keywords" content="G protein-activated inward rectifier potassium channel 4" /><meta name="citation_keywords" content="Inward rectifier potassium channel 2" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily E member 1" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily E member 2" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily H member 2" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily KQT member 1" /><meta name="citation_keywords" content="Sodium channel protein type 5 subunit alpha" /><meta name="citation_keywords" content="Sodium channel subunit beta-4" /><meta name="citation_keywords" content="Voltage-dependent L-type calcium channel subunit alpha-1C" /><meta name="citation_keywords" content="AKAP9" /><meta name="citation_keywords" content="ANK2" /><meta name="citation_keywords" content="CACNA1C" /><meta name="citation_keywords" content="CALM1" /><meta name="citation_keywords" content="CALM2" /><meta name="citation_keywords" content="CAV3" /><meta name="citation_keywords" content="KCNE1" /><meta name="citation_keywords" content="KCNE2" /><meta name="citation_keywords" content="KCNH2" /><meta name="citation_keywords" content="KCNJ2" /><meta name="citation_keywords" content="KCNJ5" /><meta name="citation_keywords" content="KCNQ1" /><meta name="citation_keywords" content="SCN4B" /><meta name="citation_keywords" content="SCN5A" /><meta name="citation_keywords" content="SNTA1" /><meta name="citation_keywords" content="Long QT Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Long QT Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Mariëlle Alders" /><meta name="DC.Contributor" content="Hennie Bikker" /><meta name="DC.Contributor" content="Imke Christiaans" /><meta name="DC.Date" content="2018/02/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1129/" /><meta name="description" content="Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome." /><meta name="og:title" content="Long QT Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1129/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/rws/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1129/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88434BDFC837910000000007950362.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1129_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1129_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/loeys-dietz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lowe/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1129_"><span class="title" itemprop="name">Long QT Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Mari&#x000eb;lle Alders</span>, PhD, <span itemprop="author">Hennie Bikker</span>, PhD, and <span itemprop="author">Imke Christiaans</span>, PhD, MD.</p><a data-jig="ncbitoggler" href="#__NBK1129_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1129_ai__"><div class="contrib half_rhythm"><span itemprop="author">Mari&#x000eb;lle Alders</span>, PhD<div class="affiliation small">Department of Clinical Genetics<br />Academic Medical Center<br />University of Amsterdam<br />Amsterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.avu.cma@sredla.m" class="oemail">ln.avu.cma@sredla.m</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hennie Bikker</span>, PhD<div class="affiliation small">Department of Clinical Genetics<br />Academic Medical Center<br />University of Amsterdam<br />Amsterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.avu.cma@rekkib.h" class="oemail">ln.avu.cma@rekkib.h</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Imke Christiaans</span>, PhD, MD<div class="affiliation small">Department of Clinical Genetics<br />Academic Medical Center<br />University of Amsterdam<br />Amsterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.avu.cma@snaaitsirhc.i" class="oemail">ln.avu.cma@snaaitsirhc.i</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 20, 2003</span>; Last Update: <span itemprop="dateModified">February 8, 2018</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="rws.Summary" itemprop="description"><h2 id="_rws_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia <i>torsade de pointes</i> (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis of LQTS is established by prolongation of the QTc interval in the absence of specific conditions known to lengthen it (for example, QT-prolonging drugs) and/or by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> that identifies a diagnostic change (or changes) in one or more of the 15 genes known to be associated with LQTS &#x02013; of which <i>KCNH2</i> (LQT2), <i>KCNQ1</i> (<a class="def" href="/books/n/gene/glossary/def-item/locus-name/">locus name</a> LQT1), and <i>SCN5A</i> (LQT3) are the most common. Approximately 20% of families meeting clinical diagnostic criteria for LQTS do not have detectable pathogenic variants in a known <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. LQTS associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants or heterozygosity for pathogenic variants in two different genes (i.e., <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> pathogenic variants) is generally associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with longer QTc interval.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Beta blocker medication is the primary treatment for LQTS; possible implantable cardioverter-defibrillators (ICD) and/or left cardiac sympathetic denervation (LCSD) for those with beta-blocker-resistant symptoms, inability to take beta blockers, and/or history of cardiac arrest. Sodium channel blockers can be useful as additional pharmacologic therapy for patients with a QTc interval &#x0003e;500 ms.</p><p><i>Prevention of primary manifestations:</i> Beta blockers are clinically indicated in all asymptomatic individuals meeting diagnostic criteria, including those who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on molecular testing and a normal QTc interval. In general, ICD implantation is not indicated for individuals with LQTS who are asymptomatic and who have not been tried on beta blocker therapy. Prophylactic ICD therapy can be considered for individuals with LQTS who are asymptomatic but suspected to be at very high risk (e.g., those with &#x02265;2 pathogenic variants on molecular testing).</p><p><i>Surveillance:</i> Regular assessment of beta blocker dose for efficacy and adverse effects in all individuals with LQTS, especially children during rapid growth; regular periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p><p><i>Agents/circumstances to avoid:</i> Drugs that cause further prolongation of the QT interval or provoke <i>torsade de pointes</i>; competitive sports / activities associated with intense physical activity and/or emotional stress for most individuals.</p><p><i>Evaluation of relatives at risk:</i> Presymptomatic diagnosis and treatment is warranted in relatives at risk to prevent syncope and sudden death.</p><p><i>Other:</i> For some individuals, availability of automatic external defibrillators at home, at school, and in play areas.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>LQTS is typically inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. An exception is LQTS associated with sensorineural deafness (known as Jervell and Lange-Nielsen syndrome), which is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Most individuals diagnosed with LQTS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of LQTS caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is small. Each child of an individual with autosomal dominant LQTS has a 50% risk of inheriting the pathogenic variant. Penetrance of the disorder may vary. Prenatal testing for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible once the pathogenic variant(s) have been identified in the family.</p></div></div><div id="rws.Diagnosis"><h2 id="_rws_Diagnosis_">Diagnosis</h2><div id="rws.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Long QT syndrome (LQTS) <b>should be suspected</b> in individuals on the basis of ECG characteristics, clinical presentation, and family history.</p><div id="rws.ECG_Evaluation"><h4>ECG Evaluation</h4><p><b>Corrected QT (QTc) values on resting ECG.</b> The QTc on resting ECG is neither completely sensitive nor specific for the diagnosis of LQTS. Approximately 25% of individuals with LQTS confirmed by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a LQTS-associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> may have a normal range QTc (concealed LQTS) [<a class="bk_pop" href="#rws.REF.goldenberg.2011.51">Goldenberg et al 2011</a>]. Also, several other factors can lengthen the QTc interval:</p><ul><li class="half_rhythm"><div>QT-prolonging drugs</div></li><li class="half_rhythm"><div>Hypokalemia</div></li><li class="half_rhythm"><div>Certain neurologic conditions including subarachnoid bleed</div></li><li class="half_rhythm"><div>Structural heart disease</div></li></ul><p>The following tests are helpful for further evaluation of individuals with "uncertain" QTc values on resting ECG:</p><ul><li class="half_rhythm"><div><b>Exercise ECG,</b> which commonly shows failure of the QTc to shorten normally and even prolongation of the QTc interval [<a class="bk_pop" href="#rws.REF.jervell.1957.59">Jervell &#x00026; Lange-Nielsen 1957</a>, <a class="bk_pop" href="#rws.REF.vincent.1991.498">Vincent et al 1991</a>, <a class="bk_pop" href="#rws.REF.swan.1998.508">Swan et al 1998</a>, <a class="bk_pop" href="#rws.REF.horner.2011.1698">Horner et al 2011</a>, <a class="bk_pop" href="#rws.REF.sy.2011.2187">Sy et al 2011</a>]. Many individuals develop characteristic T-wave abnormalities [<a class="bk_pop" href="#rws.REF.zhang.2000.2849">Zhang et al 2000</a>].</div></li><li class="half_rhythm"><div><b>QTc interval measurement</b> during change from supine to standing position [<a class="bk_pop" href="#rws.REF.viskin.2010.1955">Viskin et al 2010</a>]</div></li><li class="half_rhythm"><div><b>Intravenous pharmacologic provocation</b>
<b>testing</b> (e.g., with epinephrine), which may be helpful by demonstrating inappropriate prolongation of the QTc interval [<a class="bk_pop" href="#rws.REF.ackerman.2002.413">Ackerman et al 2002</a>]. With the small risk of induction of arrhythmia, such provocative testing is best performed in laboratories experienced in arrhythmia induction and control [<a class="bk_pop" href="#rws.REF.shimizu.2004.276">Shimizu et al 2004</a>, <a class="bk_pop" href="#rws.REF.vyas.2006.1385">Vyas et al 2006</a>].</div></li></ul></div><div id="rws.Clinical_History"><h4>Clinical History</h4><p>A personal history of syncope, aborted cardiac arrest, or sudden death in a child or young adult may lead to suspicion of LQTS. The syncope is typically precipitous and without warning, thus differing from the common vasovagal and orthostatic forms of syncope in which presyncope and other warning symptoms occur. Absence of aura, incontinence, and postictal findings help differentiate LQTS-associated syncope from seizures.</p></div><div id="rws.Family_History"><h4>Family History</h4><p>A family history of syncope, aborted cardiac arrest, or sudden death in a child or young adult and consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance supports the diagnosis of LQTS.</p></div></div><div id="rws.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><a class="bk_pop" href="#rws.REF.schwartz.1993.782">Schwartz et al [1993]</a> proposed a scoring system to diagnose LQTS on a clinical basis; it was updated by <a class="bk_pop" href="#rws.REF.schwartz.2011.2181">Schwartz &#x00026; Crotti [2011]</a>. Points are assigned to various criteria (see <a class="figpopup" href="/books/NBK1129/table/rws.T.scoring_system_for_clinical_diagno/?report=objectonly" target="object" rid-figpopup="figrwsTscoringsystemforclinicaldiagno" rid-ob="figobrwsTscoringsystemforclinicaldiagno">Table 1</a>).</p><div id="rws.T.scoring_system_for_clinical_diagno" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Scoring System for Clinical Diagnosis of Long QT Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.T.scoring_system_for_clinical_diagno/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.T.scoring_system_for_clinical_diagno_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Findings</th><th id="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Points</th></tr></thead><tbody><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="8" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>ECG&#x000a0;<sup>1</sup></b></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">QTc&#x000a0;<sup>2</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02265;480 ms</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">=460-479 ms</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">=450-459 ms (in males)</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02265;480 ms during 4<sup>th</sup> minute of recovery from exercise stress test</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>Torsade de pointes</i>&#x000a0;<sup>3</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">T wave alternans</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Notched T wave in 3 leads</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Low heart rate for age&#x000a0;<sup>4</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.5</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Clinical history</b></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Syncope&#x000a0;<sup>3</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">With stress</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Without stress</td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family history</b></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">Family member(s) with definite LQTS&#x000a0;<sup>5</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Unexplained sudden cardiac death at age &#x0003c;30 years in immediate family&#x000a0;<sup>5</sup></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.5</td></tr><tr><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_1" colspan="3" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total score</b></td><td headers="hd_h_rws.T.scoring_system_for_clinical_diagno_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Adapted from <a class="bk_pop" href="#rws.REF.schwartz.2011.2181">Schwartz &#x00026; Crotti [2011]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">Scoring:</p></div></dd><dt></dt><dd><div><p class="no_margin">&#x02264;1.0 point = low probability of LQTS</p></div></dd><dt></dt><dd><div><p class="no_margin">1.5-3.0 points = intermediate probability of LQTS</p></div></dd><dt></dt><dd><div><p class="no_margin">&#x02265;3.5 points = high probability of LQTS</p></div></dd><dt></dt><dd><div><p class="no_margin">Footnotes:</p></div></dd><dt>1. </dt><dd><div id="rws.TF.1.1"><p class="no_margin">In the absence of medications or disorders known to affect these electrocardiographic features</p></div></dd><dt>2. </dt><dd><div id="rws.TF.1.2"><p class="no_margin">QTc (corrected QT) calculated by Bazett's formula where QTc = QT/&#x0221a;RR</p></div></dd><dt>3. </dt><dd><div id="rws.TF.1.3"><p class="no_margin">Mutually exclusive</p></div></dd><dt>4. </dt><dd><div id="rws.TF.1.4"><p class="no_margin">Resting heart rate &#x0003c;2nd %ile for age</p></div></dd><dt>5. </dt><dd><div id="rws.TF.1.5"><p class="no_margin">The same family member cannot be counted for both criteria.</p></div></dd></dl></div></div></div><p>The diagnosis of LQTS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with one or more of the following [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]:</p><ul><li class="half_rhythm"><div>A risk score of &#x02265;3.5 (see <a class="figpopup" href="/books/NBK1129/table/rws.T.scoring_system_for_clinical_diagno/?report=objectonly" target="object" rid-figpopup="figrwsTscoringsystemforclinicaldiagno" rid-ob="figobrwsTscoringsystemforclinicaldiagno">Table 1</a>) in the absence of a secondary cause for QT prolongation</div></li><li class="half_rhythm"><div>The presence of a corrected QT interval &#x02265;500 ms in repeated ECGs in the absence of a secondary cause for QT prolongation</div></li><li class="half_rhythm"><div>The identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the known to be associated with LQTS (see <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_long_qt_synd/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflongqtsynd" rid-ob="figobrwsTmoleculargeneticsoflongqtsynd">Tables 2a</a> and <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_lqts_less_co/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflqtslessco" rid-ob="figobrwsTmoleculargeneticsoflqtslessco">2b</a>)</div></li></ul><p>Molecular genetic testing approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes the genes listed in <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_long_qt_synd/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflongqtsynd" rid-ob="figobrwsTmoleculargeneticsoflongqtsynd">Tables 2a</a> and <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_lqts_less_co/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflqtslessco" rid-ob="figobrwsTmoleculargeneticsoflqtslessco">2b</a> and other genes of interest (see <a href="#rws.Differential_Diagnosis">Differential Diagnosis</a>) is recommended for molecular diagnosis. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></b>
<b>testing.</b> Molecular genetic testing based on the individual's <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (T-wave pattern and triggers of syncope), which has been shown to predict the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> [<a class="bk_pop" href="#rws.REF.zhang.2000.2849">Zhang et al 2000</a>, <a class="bk_pop" href="#rws.REF.van_langen.2003.141">Van Langen et al 2003</a>] (see <a class="figpopup" href="/books/NBK1129/table/rws.T.phenotype_correlations_by_gene/?report=objectonly" target="object" rid-figpopup="figrwsTphenotypecorrelationsbygene" rid-ob="figobrwsTphenotypecorrelationsbygene">Table 3</a>) can be performed. Sequence analysis is performed first; it may be followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="rws.T.molecular_genetics_of_long_qt_synd" class="table"><h3><span class="label">Table 2a. </span></h3><div class="caption"><p>Molecular Genetics of Long QT Syndrome (LQTS): Most Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.T.molecular_genetics_of_long_qt_synd/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.T.molecular_genetics_of_long_qt_synd_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,2</sup></th><th id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_2" style="text-align:left;vertical-align:middle;">LQTS Phenotype</th><th id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_3" style="text-align:left;vertical-align:middle;">% of LQTS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4" id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4" id="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNH2</i></td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 2</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25%-30%</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97%-98%</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%-3%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ1</i></td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 1&#x000a0;<sup>7</sup></td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%-35%</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97%-98%</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%-3%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN5A</i></td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 3</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10%</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All variants reported to date</td><td headers="hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_1_4 hd_h_rws.T.molecular_genetics_of_long_qt_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes included in this table account for &#x0003e;1% of LQTS.</p></div></dd><dt>1. </dt><dd><div id="rws.TF.2a.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="rws.TF.2a.2"><p class="no_margin">See <a href="/books/NBK1129/#rws.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="rws.TF.2a.3"><p class="no_margin">See <a href="#rws.Molecular_Genetics">Molecular Genetics</a> for information on pathogenic variants detected.</p></div></dd><dt>4. </dt><dd><div id="rws.TF.2a.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="rws.TF.2a.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="rws.TF.2a.6"><p class="no_margin">Deletions or duplications involving <i>KCNH1 or KCNQ2</i> have been shown to be causal for LQTS in ~3% of cases [<a class="bk_pop" href="#rws.REF.barc.2011.40">Barc et al 2011</a>].</p></div></dd><dt>7. </dt><dd><div id="rws.TF.2a.7"><p class="no_margin">Biallelic pathogenic variants in <i>KCNQ1</i> are associated with <a href="/books/n/gene/jln/">Jervell and Lange-Nielsen syndrome</a>.</p></div></dd><dt>8. </dt><dd><div id="rws.TF.2a.8"><p class="no_margin">The pathogenic variants in <i>SCN5A</i> that cause LQTS are <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants (<a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants of <i>SCN5A</i> cause <a href="/books/n/gene/brugada/">Brugada syndrome</a>). Therefore, it is highly unlikely that large deletions or duplications in <i>SCN5A</i> will be identified as a cause of LQTS.</p></div></dd></dl></div></div></div><div id="rws.T.molecular_genetics_of_lqts_less_co" class="table"><h3><span class="label">Table 2b. </span></h3><div class="caption"><p>Molecular Genetics of LQTS: Less Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.T.molecular_genetics_of_lqts_less_co/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.T.molecular_genetics_of_lqts_less_co_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1&#x000a0;,2,&#x000a0;3</sup></th><th id="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS Phenotype</th><th id="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AKAP9</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 11</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Limited&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANK2</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 4</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CACNA1C</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 8&#x000a0;<sup>6</sup></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CALM1</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 14</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CALM2</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 15</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CAV3</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 9</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNE1</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 5&#x000a0;<sup>8</sup></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNE2</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 6</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNJ2</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 7&#x000a0;<sup>10</sup></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>5</sup>,&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNJ5</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 13</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>12</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN4B</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 10</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limited&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SNTA1</i></td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LQTS type 12</td><td headers="hd_h_rws.T.molecular_genetics_of_lqts_less_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;1%&#x000a0;<sup>13</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., &#x0003c;1% of LQTS). See also <a href="https://www.clinicalgenome.org/curation-activities/gene-disease-validity/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinGen</a>.</p></div></dd><dt>1. </dt><dd><div id="rws.TF.2b.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="rws.TF.2b.2"><p class="no_margin">See <a href="/books/NBK1129/#rws.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="rws.TF.2b.3"><p class="no_margin">Genes are not described in detail in Molecular Genetics, but are included <a href="/books/NBK1129/bin/rws-less_common_genes.pdf">here</a> (pdf).</p></div></dd><dt>4. </dt><dd><div id="rws.TF.2b.4"><p class="no_margin"><a class="bk_pop" href="#rws.REF.chen.2007.20990">Chen et al [2007]</a></p></div></dd><dt>5. </dt><dd><div id="rws.TF.2b.5"><p class="no_margin"><a class="bk_pop" href="#rws.REF.kapplinger.2009.1297">Kapplinger et al [2009]</a></p></div></dd><dt>6. </dt><dd><div id="rws.TF.2b.6"><p class="no_margin">LQTS type 8 is also referred to as <a href="/books/n/gene/timothy/">Timothy syndrome</a>.</p></div></dd><dt>7. </dt><dd><div id="rws.TF.2b.7"><p class="no_margin"><a class="bk_pop" href="#rws.REF.kimura.2012.344">Kimura et al [2012]</a></p></div></dd><dt>8. </dt><dd><div id="rws.TF.2b.8"><p class="no_margin">Biallelic pathogenic variants in <i>KCNE1</i> are associated with <a href="/books/n/gene/jln/">Jervell and Lange-Nielsen syndrome</a>.</p></div></dd><dt>9. </dt><dd><div id="rws.TF.2b.9"><p class="no_margin"><a class="bk_pop" href="#rws.REF.lieve.2013.553">Lieve et al [2013]</a></p></div></dd><dt>10. </dt><dd><div id="rws.TF.2b.10"><p class="no_margin">LQTS type 7 is also referred to as <a href="/books/n/gene/acpp/">Andersen-Tawil syndrome</a>.</p></div></dd><dt>11. </dt><dd><div id="rws.TF.2b.11"><p class="no_margin"><a class="bk_pop" href="#rws.REF.shigemizu.2015.e0130329">Shigemizu et al [2015]</a></p></div></dd><dt>12. </dt><dd><div id="rws.TF.2b.12"><p class="no_margin"><a class="bk_pop" href="#rws.REF.yang.2010.872">Yang et al [2010]</a></p></div></dd><dt>13. </dt><dd><div id="rws.TF.2b.13"><p class="no_margin"><a class="bk_pop" href="#rws.REF.crotti.2013.1009">Crotti et al [2013]</a></p></div></dd></dl></div></div></div><p>Note: Approximately 20% of families with a clinically firm diagnosis of LQTS do not have a detectable <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the 15 genes (<i>AKAP9</i>, <i>ANK2</i>, <i>CACNA1C</i>, <i>CALM1</i>, <i>CALM2</i>, <i>CAV3</i>, <i>KCNE1</i>, <i>KCNE2</i>, <i>KCNH2</i>, <i>KCNJ2</i>, <i>KCNJ5</i>, <i>KCNQ1</i>, <i>SCN4B</i>, <i>SCN5A</i>, and <i>SNTA1</i>) known to be associated with LQTS, suggesting that pathogenic variants in other genes can also cause LQTS and/or that current test methods do not detect all pathogenic variants in the known genes [<a class="bk_pop" href="#rws.REF.schwartz.2012.868">Schwartz et al 2012</a>, <a class="bk_pop" href="#rws.REF.giudicessi.2013.417">Giudicessi &#x00026; Ackerman 2013</a>].</p></div></div><div id="rws.Clinical_Characteristics"><h2 id="_rws_Clinical_Characteristics_">Clinical Characteristics</h2><div id="rws.Clinical_Description"><h3>Clinical Description</h3><p>Long QT syndrome (LQTS) is characterized by QT prolongation and T-wave abnormalities on ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia <i>torsade de pointes</i> (TdP). TdP is usually self-terminating, thus causing syncope, the most common symptom in individuals with LQTS. Syncope is typically precipitous and without warning. In some instances, TdP degenerates to ventricular fibrillation and aborted cardiac arrest (if the individual is defibrillated) or sudden death.</p><p>Approximately 50% or fewer of untreated individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the 15 genes (see <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_long_qt_synd/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflongqtsynd" rid-ob="figobrwsTmoleculargeneticsoflongqtsynd">Table 2a</a>, <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_lqts_less_co/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflqtslessco" rid-ob="figobrwsTmoleculargeneticsoflqtslessco">Table 2b</a>) associated with LQTS have symptoms [<a class="bk_pop" href="#rws.REF.vincent.1992.846">Vincent et al 1992</a>, <a class="bk_pop" href="#rws.REF.zareba.1998.960">Zareba et al 1998</a>]. The number of syncopal events in symptomatic individuals ranges from one to hundreds, averaging just a few.</p><div id="rws.Most_Common_Phenotypes"><h4>Most Common Phenotypes</h4><p>Pathogenic variants in <i>KCNH2</i>, <i>KCNQ1</i>, and <i>SCN5A</i> account for the vast majority of cases of LQTS and distinct <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been reported (see <a class="figpopup" href="/books/NBK1129/table/rws.T.phenotype_correlations_by_gene/?report=objectonly" target="object" rid-figpopup="figrwsTphenotypecorrelationsbygene" rid-ob="figobrwsTphenotypecorrelationsbygene">Table 3</a>). Three clinical phenotypes (LQTS types 1, 2, and 3) are recognized in individuals with pathogenic variants in these genes.</p><ul><li class="half_rhythm"><div>QTc range is similar across phenotypes (~400-600+ msec). The average QTc values are similar for the LQTS type 1 and LQTS type 2 phenotypes and somewhat longer for the LQTS type 3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div>T-wave patterns characteristic for the LQTS type 1, 2, and 3 phenotypes have been reported and can assist in directing <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategies to identify the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved [<a class="bk_pop" href="#rws.REF.zhang.2000.2849">Zhang et al 2000</a>].</div></li><li class="half_rhythm"><div>Cardiac events often have <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-specific triggers [<a class="bk_pop" href="#rws.REF.schwartz.2001.89">Schwartz et al 2001</a>]. In the LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> symptoms are mostly triggered by exercise while in the LQTS type 2 phenotype events are mostly triggered by auditory stimuli and emotional stress. In the LQTS type 3 phenotype symptoms mostly occur during sleep.</div></li></ul><div id="rws.T.phenotype_correlations_by_gene" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Phenotype Correlations by Gene</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.T.phenotype_correlations_by_gene/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.T.phenotype_correlations_by_gene_lrgtbl__"><table><thead><tr><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Average QTc</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ST-T-Wave Morphology</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incidence of Cardiac Events</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac Event Trigger</th><th id="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sudden Death Risk</th></tr></thead><tbody><tr><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNH2</i></td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 2</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">480 msec</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bifid T-waves</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">46%</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Auditory stimuli, emotion, exercise, sleep</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-8%</td></tr><tr><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ1</i></td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 1</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">Broad-base T-wave</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63%</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exercise, emotion</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-8%</td></tr><tr><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN5A</i></td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LQTS type 3</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~490 msec</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Long ST, small T</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18%</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep</td><td headers="hd_h_rws.T.phenotype_correlations_by_gene_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-8%</td></tr></tbody></table></div></div></div><div id="rws.AgeRelated_Risk"><h4>Age-Related Risk</h4><p>Cardiac events may occur from infancy through middle age but are most common from the preteen years through the 20s, with the risk generally diminishing throughout that time period. The usual age range of events differs somewhat for each <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>. Cardiac events are uncommon after age 40 years; when present, they are often triggered by administration of a QT-prolonging drug or hypokalemia or are associated with the LQTS type 3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="rws.Overall_Risk_for_Cardiac_Events"><h4>Overall Risk for Cardiac Events</h4><p>Of individuals who die of complications of LQTS, death is the first sign of the disorder in an estimated 10%-15%. It is difficult to establish numbers on the risk of cardiac events in LQTS since most individuals are treated.</p><ul><li class="half_rhythm"><div class="half_rhythm">Studies from the long QT syndrome registry including patients, individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (mostly treated), and also relatives who died suddenly show a cumulative mortality before age 40 years of 6%-8% in the LQTS type 1, type 2, and type 3 phenotypes [<a class="bk_pop" href="#rws.REF.zareba.1998.960">Zareba et al 1998</a>, <a class="bk_pop" href="#rws.REF.goldenberg.2008.629">Goldenberg et al 2008</a>].</div><ul><li class="half_rhythm"><div>In individuals between age 0 and 18 years, those with a LQTS type 1, type 2, or type 3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> had a cumulative mortality of 2%, 3%, and 7%, respectively.</div></li><li class="half_rhythm"><div>From age 19 to 40 years mortality rates were 5%, 7%, and 5%, respectively.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Although syncopal events are most common in the LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (63%), followed by the LQTS type 2 phenotype (46%) and LQTS type 3 phenotype (18%), the incidence of death is similar in all three.</div></li><li class="half_rhythm"><div class="half_rhythm">A study using the family tree mortality rate method studied mortality in large families with LQTS, in times when disease was not known and individuals received no treatment, compared to the normal population.</div><div class="half_rhythm">For the LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (one specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>), severely increased mortality was shown throughout childhood (ages 1-19 years), for the type 2 phenotype, increased mortality between ages 15 and 39 years was seen, and in the type 3 phenotype, increased mortality between ages 15 and 19 years was seen [<a class="bk_pop" href="#rws.REF.nannenberg.2012.183">Nannenberg et al 2012</a>].</div></li></ul></div><div id="rws.NonCardiac_Features"><h4>Non-Cardiac Features</h4><p>Some types of LQTS are associated with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> extending beyond cardiac arrhythmia:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/acpp/">Andersen-Tawil syndrome</a> (LQTS type 7) is associated with prolonged QT interval, muscle weakness, and facial dysmorphism.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/timothy/">Timothy syndrome</a> (LQTS type 8) is characterized by prolonged QT interval and hand/foot, facial, and neurodevelopmental features.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/jln/">Jervell and Lange-Nielson syndrome</a> (JLNS), an LQTS disorder associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic <i>KCNQ1</i> or <i>KCNE1</i> variants, is associated with profound sensorineural hearing loss.</div></li></ul></div></div><div id="rws.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Long QT syndrome (LQTS) associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants or heterozygosity for pathogenic variants in two different genes (i.e., <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> pathogenic variants) is generally associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with longer QTc interval and a higher incidence of cardiac events [<a class="bk_pop" href="#rws.REF.schwartz.2003.1120">Schwartz et al 2003</a>, <a class="bk_pop" href="#rws.REF.westenskow.2004.1834">Westenskow et al 2004</a>, <a class="bk_pop" href="#rws.REF.tester.2005.507">Tester et al 2005</a>, <a class="bk_pop" href="#rws.REF.itoh.2010.1411">Itoh et al 2010</a>].</p><p>There are no specific <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> known other than as noted in <a href="#rws.Clinical_Description">Clinical Description</a>.</p></div><div id="rws.Penetrance"><h3>Penetrance</h3><p>LQTS exhibits reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the ECG changes and symptoms. Overall, approximately 25% of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a normal QTc (defined as &#x0003c;440 msec) on baseline ECG. The percentage of genetically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a normal QTc was higher in the LQTS type 1 group (36%) than in the LQTS type 2 group (19%) or type 3 group (10%) [<a class="bk_pop" href="#rws.REF.priori.2003.1866">Priori et al 2003</a>, <a class="bk_pop" href="#rws.REF.goldenberg.2011.51">Goldenberg et al 2011</a>].</p><p>As noted in <a class="figpopup" href="/books/NBK1129/table/rws.T.phenotype_correlations_by_gene/?report=objectonly" target="object" rid-figpopup="figrwsTphenotypecorrelationsbygene" rid-ob="figobrwsTphenotypecorrelationsbygene">Table 3</a>, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for symptoms is also reduced. At least 37% of individuals with the LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, 54% with the type 2 phenotype, and 82% with the type 3 phenotype remain asymptomatic.</p></div><div id="rws.Nomenclature"><h3>Nomenclature</h3><p>The term "Romano-Ward syndrome" refers to forms of long QT syndrome with a purely cardiac <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (LQTS types 1-3, type 5, type 6, and types 9-15).</p></div><div id="rws.Prevalence"><h3>Prevalence</h3><p>The prevalence of LQTS has been estimated at 1:2,500 [<a class="bk_pop" href="#rws.REF.schwartz.2009.113">Schwartz et al 2009</a>, <a class="bk_pop" href="#rws.REF.giudicessi.2013.417">Giudicessi &#x00026; Ackerman 2013</a>, <a class="bk_pop" href="#rws.REF.lieve.2015.ii1">Lieve &#x00026; Wilde 2015</a>].</p><p>LQTS has been identified in all ethnic groups.</p></div></div><div id="rws.Genetically_Related_Allelic_Disorder"><h2 id="_rws_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><a href="/books/n/gene/brugada/"><b>Brugada syndrome</b></a><b>.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>SCN5A</i> are associated with cardiac conduction defects including rapid polymorphic ventricular tachycardia / ventricular fibrillation and sudden death.</p><p><b>Caveolinopathies.</b> Pathogenic variants in <i>CAV3</i> (OMIM <a href="https://www.omim.org/entry/601253" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601253</a>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding caveolin-3, have been associated with sudden infant death syndrome (SIDS) and also with LQT syndrome (LQTS type 9) [<a class="bk_pop" href="#rws.REF.vatta.2006.2104">Vatta et al 2006</a>, <a class="bk_pop" href="#rws.REF.arnestad.2007.361">Arnestad et al 2007</a>, <a class="bk_pop" href="#rws.REF.cronk.2007.161">Cronk et al 2007</a>]. <i>CAV3</i> pathogenic variants cause an increase in late sodium current similar to that seen in the LQTS type 3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. <i>CAV3</i> pathogenic variants are also associated with a range of muscular disease. While several distinct muscular phenotypes (e.g., limb-girdle muscular dystrophy, distal myopathy) have been described, many patients have overlapping muscular phenotypes. Genotype/phenotype correlations are absent and clinical variability is large.</p><p><i>ANK2</i> pathogenic variants can cause a broad spectrum of clinical cardiac phenotypes, including <a href="/books/n/gene/cvt/">catecholaminergic polymorphic ventricular arrhythmias</a>, sinus node dysfunction, and atrial fibrillation [<a class="bk_pop" href="#rws.REF.mohler.2003.634">Mohler et al 2003</a>, <a class="bk_pop" href="#rws.REF.mohler.2007.432">Mohler et al 2007</a>].</p></div><div id="rws.Differential_Diagnosis"><h2 id="_rws_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Other causes of QTc interval prolongation</b> to be considered:</p><ul><li class="half_rhythm"><div>QT-prolonging drugs</div></li><li class="half_rhythm"><div>Hypokalemia</div></li><li class="half_rhythm"><div>Certain neurologic conditions including subarachnoid bleed</div></li><li class="half_rhythm"><div>Structural heart disease</div></li></ul><p><b>Other causes of syncope or sudden death</b> to be considered in children and young adults:</p><ul><li class="half_rhythm"><div>Sudden infant death syndrome (SIDS), commonly defined as unexpected sudden death within the first year of life. Death during the first year of life in families with LQTS appears to be rare, yet a percent of infants dying of SIDS have been shown to have pathogenic variants in one of the LQTS-related genes [<a class="bk_pop" href="#rws.REF.ackerman.2001.2264">Ackerman et al 2001</a>, <a class="bk_pop" href="#rws.REF.schwartz.2001.89">Schwartz et al 2001</a>, <a class="bk_pop" href="#rws.REF.arnestad.2007.361">Arnestad et al 2007</a>]. While it seems probable that these pathogenic variants were the cause of the SIDS, the association is uncertain, and the frequency of pathogenic variants in SIDS cases has been questioned [<a class="bk_pop" href="#rws.REF.wedekind.2006.129">Wedekind et al 2006</a>].</div></li><li class="half_rhythm"><div>Vasovagal (neurally mediated) syncope, orthostatic hypotension</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Familial ventricular fibrillation</div></li><li class="half_rhythm"><div>Subtle cardiomyopathies (<a href="/books/n/gene/hyper-card/">HCM</a>, <a href="/books/n/gene/dcm-ov/">DCM</a>, <a href="/books/n/gene/arvd/">ARVC</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cvt/">Catecholaminergic polymorphic ventricular tachycardia</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/brugada/">Brugada syndrome</a></div></li><li class="half_rhythm"><div>Anomalous coronary artery</div></li><li class="half_rhythm"><div>Drug-induced QT prolongation (see drugs at <a href="https://www.crediblemeds.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CredibleMeds<sup>&#x000ae;</sup></a>)</div></li></ul></div><div id="rws.Management"><h2 id="_rws_Management_">Management</h2><div id="rws.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with LQTS, the main focus in the management of individuals with LQTS is to identify the subset of individuals at high risk for cardiac events. For this risk stratification the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div><b>ECG evaluation.</b> Individuals with a QTc interval &#x0003e;500 ms are at higher risk for an event; individuals with QTc interval &#x0003e;600 ms are at extremely high risk [<a class="bk_pop" href="#rws.REF.priori.2003.1866">Priori et al 2003</a>, <a class="bk_pop" href="#rws.REF.goldenberg.2008.629">Goldenberg et al 2008</a>]. Overt T-wave alternans, especially when present despite proper beta blocker therapy, is also associated with a higher risk for cardiac events [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]. Individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who have a normal QTc interval are at low risk [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Medical history.</b> Individuals with syncope or cardiac arrest in the first year of life [<a class="bk_pop" href="#rws.REF.schwartz.2009.113">Schwartz et al 2009</a>, <a class="bk_pop" href="#rws.REF.spazzolini.2009.832">Spazzolini et al 2009</a>] or younger than age seven years [<a class="bk_pop" href="#rws.REF.priori.2004.1341">Priori et al 2004</a>] are at higher risk. These individuals may not be fully protected by pharmacologic treatment. Individuals with arrhythmic events while on proper pharmacologic treatment are also at higher risk [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]. Asymptomatic individuals with pathogenic variants or individuals with prolonged QT intervals who have been asymptomatic at a young age (age &#x0003c;40 years) are at low risk for events later in life, although females remain at risk after age 40 years [<a class="bk_pop" href="#rws.REF.locati.1998.2237">Locati et al 1998</a>].</div></li><li class="half_rhythm"><div><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="rws.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>All symptomatic persons should be treated (see <a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al [2013]</a>). Complete cessation of symptoms is the goal. Management is focused on the prevention of syncope, cardiac arrest, and sudden death through use of the following:</p><ul><li class="half_rhythm"><div><b>Beta blockers</b> are the mainstay of therapy for LQTS, including asymptomatic individuals with prolonged QT intervals and individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on molecular testing with a normal QTc interval [<a class="bk_pop" href="#rws.REF.priori.2004.1341">Priori et al 2004</a>, <a class="bk_pop" href="#rws.REF.schwartz.2009.113">Schwartz et al 2009</a>]. Some individuals have symptoms despite the use of beta blockers [<a class="bk_pop" href="#rws.REF.moss.2000.616">Moss et al 2000</a>]. However, a majority of cardiac events that occur in individuals with LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> "on beta blockers" are not caused by failure of the medication, but in fact by failure to take the medication (non-compliance) and/or the administration of QT-prolonging drugs [<a class="bk_pop" href="#rws.REF.vincent.2009.215">Vincent et al 2009</a>]. It is suspected that the same holds true for individuals with LQTS type 2, but that has not been systematically studied. It is therefore important to:</div><ul><li class="half_rhythm"><div>Avoid inadequate beta blocker dosing by regular adjustments in growing children, with evaluation of the efficacy of dose by assessment of the exercise ECG or ambulatory ECG;</div></li><li class="half_rhythm"><div>Administer beta blockers daily, and have strategies are in place in case of missed doses;</div></li><li class="half_rhythm"><div>Use long-acting agents (e.g., nadolol) preferentially to increase compliance and avoid use of short-acting metoprolol [<a class="bk_pop" href="#rws.REF.chockalingam.2012.2092">Chockalingam et al 2012</a>];</div></li><li class="half_rhythm"><div>Administer QT-prolonging drugs (see <a href="#rws.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>) to individuals with LQTS <b>ONLY</b> after careful consideration of risk versus benefit by the individual(s) and physician(s).</div></li></ul></li><li class="half_rhythm"><div><b>Implantable cardioverter-defibrillators (ICDs)</b> are recommended in individuals with LQTS resuscitated from a cardiac arrest, although children with a LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with an arrest while not receiving beta blockers can be treated with beta blockers or with left cardiac sympathetic denervation [<a class="bk_pop" href="#rws.REF.alexander.2004.72">Alexander et al 2004</a>, <a class="bk_pop" href="#rws.REF.vincent.2009.215">Vincent et al 2009</a>, <a class="bk_pop" href="#rws.REF.jons.2010.783">Jons et al 2010</a>]. ICDs can be useful for those individuals with beta-blocker-resistant symptoms or a contraindication for beta blocker therapy (severe asthma) [<a class="bk_pop" href="#rws.REF.zareba.2003.337">Zareba et al 2003</a>, <a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Left cardiac sympathetic denervation (LCSD)</b> is recommended for high-risk patients with LQTS in whom ICD therapy is refused or contraindicated and/or in whom beta blockers are either not effective, not tolerated, not accepted, or contraindicated [<a class="bk_pop" href="#rws.REF.schwartz.2004.1826">Schwartz et al 2004</a>, <a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]. LCSD can be useful in individuals who experience events while on therapy with beta blockers or ICD [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>].</div></li><li class="half_rhythm"><div><b>Sodium channel blockers</b> can be useful as additional pharmacologic therapy for individuals with a LQTS type 3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with a QTc interval &#x0003e;500 ms in whom this additional compound is shown to shorten the QTc interval by &#x0003e;40 ms [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>].</div></li></ul><p>Note: Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals live normal lives. Education of adult individuals and the parents of affected children, especially about beta blocker compliance, is an important aspect of management.</p></div><div id="rws.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p><b>Beta blockers.</b> Beta blockers are clinically indicated in all asymptomatic individuals, including those who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on molecular testing with a normal QTc interval [<a class="bk_pop" href="#rws.REF.priori.2004.1341">Priori et al 2004</a>, <a class="bk_pop" href="#rws.REF.schwartz.2009.113">Schwartz et al 2009</a>]. Males who have a pathogenic variant and who have been asymptomatic before age 40 years are at low risk for cardiac events. In these individuals the necessity of beta blockers can be discussed [<a class="bk_pop" href="#rws.REF.locati.1998.2237">Locati et al 1998</a>].</p><p><b>ICD.</b> In general, ICD implantation is <b>not</b> indicated for asymptomatic individuals with LQTS who have not been tried on beta blocker therapy. Prophylactic ICD therapy can be considered for asymptomatic individuals suspected to be at very high risk, such as asymptomatic individuals with two or more pathogenic variants on molecular testing [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]. LQTS-related sudden death in a close relative is not an indication for an ICD in surviving relatives [<a class="bk_pop" href="#rws.REF.kaufman.2008.831">Kaufman et al 2008</a>].</p></div><div id="rws.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Examine the past medical history for asthma, orthostatic hypotension, depression, and diabetes mellitus because these disorders may be exacerbated by treatment with beta blockers.</p><p>Although the incidence of arrhythmias during elective interventions such as surgery, endoscopies, childbirth, or dental work is low, it is prudent to monitor the ECG during such interventions and to alert the appropriate medical personnel in case intervention is needed.</p></div><div id="rws.Surveillance"><h3>Surveillance</h3><p>Beta blocker dose should be regularly assessed for efficacy and adverse effects; doses should be altered as needed. Dose adjustment including efficacy testing is especially important in growing children.</p><p>Individuals with an ICD implanted should have regular, periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p></div><div id="rws.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Drugs that cause further prolongation of the QT interval or provoke <i>torsade de pointes</i> should be avoided for all individuals with LQTS. See <a href="https://www.crediblemeds.org/new-drug-list/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CredibleMeds<sup>&#x000ae;</sup></a> (free registration required) for a complete and updated list. Epinephrine given as part of local anesthetics can trigger arrhythmias and is best avoided.</p><p>Since electrolyte imbalances may also lengthen the QTc interval, identification and correction of electrolyte abnormalities is important. These imbalances can occur as a result of diarrhea, vomiting, metabolic conditions, and unbalanced diets for weight loss.</p><p>Lifestyle modifications are advised based on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>. For individuals with LQTS type 1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, avoidance of strenuous exercise &#x02013; especially swimming without supervision &#x02013; is advised. In individuals with LQTS type 2 phenotype, reduction in exposure to loud noises such as alarm clocks and phone ringing is advised. Individuals at high risk for cardiac events or with exercise-induced symptoms should avoid competitive sports [<a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>]. For some individuals participation in competitive sports may be safe. It is therefore recommended that all individuals with LQTS who wish to engage in competitive sports have their risk evaluated by a clinical expert [<a class="bk_pop" href="#rws.REF.johnson.2012.764">Johnson &#x00026; Ackerman 2012</a>, <a class="bk_pop" href="#rws.REF.priori.2013.1932">Priori et al 2013</a>].</p></div><div id="rws.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Presymptomatic diagnosis of at-risk relatives followed by treatment is necessary to prevent syncope and sudden death in those individuals who have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and/or have ECG findings consistent with LQTS. At-risk family members should be alerted to their risk and the need to be evaluated.</p><p>Relatives at high potential risk for LQTS who require further testing include members of a family:</p><ul><li class="half_rhythm"><div>That has documented LQTS;</div></li><li class="half_rhythm"><div>In which evaluation for LQTS has not been performed.</div></li></ul><p>Presymptomatic diagnosis for at-risk asymptomatic family members can be performed by <b>one</b>
<b>or both</b> of the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known</div></li><li class="half_rhythm"><div class="half_rhythm">If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not known or if genetic testing is not possible, QTc analysis on resting and in case of normal QTc also QTc analysis on exercise ECGs</div><div class="half_rhythm">Note: The diagnostic accuracy by QTc analysis is considerably improved by evaluation of the exercise ECG QTc intervals, in addition to the resting ECG, using the QTc values listed in <a class="figpopup" href="/books/NBK1129/table/rws.T.scoring_system_for_clinical_diagno/?report=objectonly" target="object" rid-figpopup="figrwsTscoringsystemforclinicaldiagno" rid-ob="figobrwsTscoringsystemforclinicaldiagno">Table 1</a>.</div></li></ul><p>Relatives at low potential risk who do not require further testing include members of a family sharing a common relative with the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> where the common relative:</p><ul><li class="half_rhythm"><div>Has a low probability of LQTS based on QTc interval (see <a class="figpopup" href="/books/NBK1129/table/rws.T.scoring_system_for_clinical_diagno/?report=objectonly" target="object" rid-figpopup="figrwsTscoringsystemforclinicaldiagno" rid-ob="figobrwsTscoringsystemforclinicaldiagno">Table 1</a>) and has not experienced LQTS-type events; or</div></li><li class="half_rhythm"><div>Has a normal QTc interval and no evidence of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes known to cause LQTS; or</div></li><li class="half_rhythm"><div>Does not have the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, if known.</div></li></ul><p>See <a href="#rws.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="rws.Pregnancy_Management"><h3>Pregnancy Management</h3><p>The postpartum period is associated with increased risk for a cardiac event, especially in individuals with the LQTS type 2 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Beta blocker treatment was associated with a reduction of events in this nine-month time period after delivery [<a class="bk_pop" href="#rws.REF.seth.2007.1092">Seth et al 2007</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="rws.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>A current study is evaluating the drug ranolazine in individuals with LQTS who have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SCN5A</i>.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="rws.Genetic_Counseling"><h2 id="_rws_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="rws.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Long QT syndrome (LQTS) is typically inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>LQTS with extracardiac signs can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. <a href="/books/n/gene/timothy/">Timothy syndrome</a> and <a href="/books/n/gene/acpp/">Andersen-Tawil syndrome</a> are inherited in an autosomal dominant manner. Jervell and Lange-Nielsen syndrome is inherited in an autosomal recessive manner (see <a href="/books/n/gene/jln/#jln.Genetic_Counseling">Jervell and Lange-Nielsen Syndrome, Genetic Counseling</a> for discussion of autosomal recessive inheritance and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> for this disorder).</p></div><div id="rws.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals diagnosed with LQTS have inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with LQTS may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is small.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (the incidence of germline mosaicism is very low: 0.17%, see <a class="bk_pop" href="#rws.REF.priest.2016.11555">Priest et al [2016]</a>).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with LQTS may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (see Management, <a href="#rws.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>).</div></li></ul><p>Note: Biallelic and <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> pathogenic variants have been described (see <a href="#rws.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>). If an individual with LQTS has <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> or digenic pathogenic variants, the possibility that both parents have pathogenic variants should be considered.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to the sibs of inheriting the pathogenic variant is 50%. Because LQTS exhibits reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, sibs who inherit a pathogenic variant may or may not have symptomatic LQTS. Considerable phenotypic variability within families has also been reported [<a class="bk_pop" href="#rws.REF.giudicessi.2013.417">Giudicessi &#x00026; Ackerman 2013</a>].</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known LQTS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent; the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#rws.REF.priest.2016.11555">Priest et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents are clinically unaffected but have not been tested for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> in sibs is estimated to be 50% because a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent may be clinically unaffected due to reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of LQTS-related ECG changes and symptoms.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with LQTS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p><p><b>Specific risk issues.</b> With the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of symptoms in individuals with LQTS, careful ECG evaluation including exercise ECG is often necessary to identify <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members accurately. The absence of a family history of sudden death is common and does not negate the diagnosis or preclude the possibility of sudden death in relatives.</p></div><div id="rws.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Testing of at-risk asymptomatic adults and children.</b> Testing of at-risk asymptomatic adults for LQTS is possible using the techniques described in Diagnosis, <a href="#rws.Establishing_the_Diagnosis">Establishing the Diagnosis</a>. Such testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. To facilitate the use of morbidity- and mortality-reducing interventions, presymptomatic testing of all at-risk family members (especially of individuals age &#x0003c;18 years, as the risk for cardiac events is greatest in childhood) should be considered (see Management, <a href="#rws.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>). When testing at-risk individuals for LQTS, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member should be tested first to identify the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. If no pathogenic variant is identified in an affected family member (the case in ~20% of families with LQTS) [<a class="bk_pop" href="#rws.REF.ackerman.2011.1308">Ackerman et al 2011</a>], at-risk relatives should undergo careful clinical examination.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="rws.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for LQTS are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="rws.Resources"><h2 id="_rws_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Long%20QT%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Long QT Syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=romanowardsyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Romano-Ward syndrome</a></div></li><li class="half_rhythm"><div><b>Canadian SADS Foundation</b></div><div>9-6975 Meadowvale Town Centre Circle</div><div>Suite 314</div><div>Mississauga Ontario L5N 2V7</div><div>Canada</div><div><b>Phone:</b> 877-525-5995 (toll-free); 905-826-6303</div><div><b>Fax:</b> 905-826-9068</div><div><b>Email:</b> info@sads.ca</div><div><a href="http://www.sads.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sads.ca</a></div></li><li class="half_rhythm"><div><b>Sudden Arrhythmia Death Syndromes (SADS) Foundation</b></div><div>508 East South Temple</div><div>Suite #202</div><div>Salt Lake City UT 84102</div><div><b>Phone:</b> 800-786-7723 (toll-free); 801-531-0937</div><div><b>Email:</b> sads@sads.org</div><div><a href="http://www.sads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sads.org</a></div></li><li class="half_rhythm"><div><b>International Long QT Syndrome Registry</b></div><div>Heart Research Follow-Up Program</div><div>Box 653</div><div>Rochester NY 14642-8653</div><div><b>Phone:</b> 585-276-0016</div><div><b>Fax:</b> 585-273-5283</div><div><b>Email:</b> heartajm@heart.rochester.edu</div></li></ul></div><div id="rws.Molecular_Genetics"><h2 id="_rws_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="rws.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Long QT Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT1</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3784" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ1</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3784" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.5-p15.4</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51787" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily KQT member 1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ LOVD</a><br /><a href="https://lovd.nl/KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ1</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT2</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3757" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNH2</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3757" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q36<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q12809" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily H member 2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNH2 database</a><br /><a href="https://lovd.nl/KCNH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNH2 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNH2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNH2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNH2</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT3</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6331" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SCN5A</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6331" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p22<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14524" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel protein type 5 subunit alpha</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/SCN5A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN5A @ LOVD</a><br /><a href="https://lovd.nl/SCN5A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN5A @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SCN5A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN5A</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SCN5A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN5A</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT4</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/287" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ANK2</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=287" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4q25-q26</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q01484" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ankyrin-2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ANK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANK2 database</a><br /><a href="https://lovd.nl/ANK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANK2 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ANK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANK2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ANK2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANK2</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT5</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3753" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNE1</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3753" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">21q22<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P15382" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily E member 1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (KCNE1)</a><br /><a href="https://lovd.nl/KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNE1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE1</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT6</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9992" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNE2</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9992" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">21q22<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y6J6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily E member 2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNE2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE2 database</a><br /><a href="https://lovd.nl/KCNE2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE2 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNE2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNE2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNE2</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT7</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3759" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNJ2</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3759" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P63252" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Inward rectifier potassium channel 2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNJ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ2 database</a><br /><a href="https://lovd.nl/KCNJ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ2 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNJ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNJ2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ2</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT8</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/775" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CACNA1C</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=775" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12p13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13936" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Voltage-dependent L-type calcium channel subunit alpha-1C</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CACNA1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1C database</a><br /><a href="https://lovd.nl/CACNA1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1C @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CACNA1C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1C</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CACNA1C[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CACNA1C</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT9</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/859" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CAV3</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=859" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p25<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P56539" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Caveolin-3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/CAV3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leiden Muscular Dystrophy pages (CAV3)</a><br /><a href="https://lovd.nl/CAV3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CAV3 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CAV3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CAV3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CAV3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CAV3</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT10</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SCN4B</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6330" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8IWT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel subunit beta-4</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SCN4B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4B database</a><br /><a href="https://lovd.nl/SCN4B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4B @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SCN4B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4B</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SCN4B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4B</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT11</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10142" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AKAP9</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10142" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q99996" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">A-kinase anchor protein 9</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/AKAP9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKAP9 database</a><br /><a href="https://lovd.nl/AKAP9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKAP9 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AKAP9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKAP9</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AKAP9[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AKAP9</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT12</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6640" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SNTA1</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6640" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13424" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alpha-1-syntrophin</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SNTA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNTA1 database</a><br /><a href="https://lovd.nl/SNTA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNTA1 @ ZAC-GGM</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SNTA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNTA1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SNTA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNTA1</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT14</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/801" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CALM1</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=801" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q32<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P62158" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Calmodulin</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CALM1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CALM1</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CALM1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CALM1</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">LQT15</td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/805" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CALM2</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=805" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p21</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P62158" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Calmodulin</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CALM2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CALM2</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CALM2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CALM2</a></td></tr><tr><td headers="hd_b_rws.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_rws.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3762" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNJ5</i></a></td><td headers="hd_b_rws.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3762" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P48544" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">G protein-activated inward rectifier potassium channel 4</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNJ5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ5 database</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNJ5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ5</a></td><td headers="hd_b_rws.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNJ5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNJ5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="rws.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="rws.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Long QT Syndrome (<a href="/omim/106410,114180,114182,114205,152427,170390,176261,192500,600163,600681,600734,600919,601005,601017,601253,603796,603830,604001,607542,608256,611818,611819,611820,612955,613485,613688,613693,613695,616247,616249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1129/table/rws.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rws.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/106410" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">106410</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANKYRIN 2; ANK2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/114180" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">114180</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CALMODULIN 1; CALM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/114182" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">114182</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CALMODULIN 2; CALM2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/114205" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">114205</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/152427" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">152427</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/170390" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">170390</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176261" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176261</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/192500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">192500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 1; LQT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600163" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600163</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600681" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600681</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600734" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600734</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600919" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600919</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601005" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601005</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TIMOTHY SYNDROME; TS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601017" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601017</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SYNTROPHIN, ALPHA-1; SNTA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601253" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601253</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CAVEOLIN 3; CAV3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603796" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603796</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2; KCNE2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603830" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603830</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 3; LQT3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604001" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604001</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">A-KINASE ANCHOR PROTEIN 9; AKAP9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607542" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607542</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608256" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608256</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, BETA SUBUNIT; SCN4B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611818" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611818</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 9; LQT9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611819" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611819</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 10; LQT10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611820</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 11; LQT11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612955" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612955</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 12; LQT12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613485" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613485</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 13; LQT13</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613688" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613688</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 2; LQT2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613693" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613693</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 6; LQT6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613695" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613695</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 5; LQT5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616247" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616247</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 14; LQT14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616249</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LONG QT SYNDROME 15; LQT15</td></tr></tbody></table></div></div><div id="rws.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The genes associated with LQTS encode for potassium or sodium cardiac ion channels or interacting proteins. Pathogenic variants in these genes cause abnormal ion channel function: a loss of function in the potassium channels and a gain of function in the sodium channel. This abnormal ion function results in prolongation of the cardiac action potential and susceptibility of the cardiac myocytes to early after depolarizations (EADs), which initiate the ventricular arrhythmia, <i>torsade de pointes</i> (TdP).</p><p>More than 1,400 pathogenic variants in the 15 LQTS-related genes have been reported and are listed in the various databases found in <a href="/books/NBK1129/#rws.molgen.TA">Table A</a>. In general, approximately 70% of pathogenic variants reported are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, 15% are frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants make up 3%-6% each. However, this distribution varies by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Radical pathogenic variants such as frameshift, nonsense, and splice site types are relatively more frequent in <i>KCNQ1</i> and <i>KCNH2</i> and are not present in <i>SCN5A</i> in individuals with LQTS (such pathogenic variants in <i>SCN5A</i> cause <a href="/books/n/gene/brugada/">Brugada syndrome</a> rather than LQTS).</p><p>For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information for the genes listed below, see <a href="/books/NBK1129/#rws.molgen.TA">Table A</a>, <b>Gene</b>.</p><div id="rws.KCNQ1"><h4><i>KCNQ1</i></h4><p><b>Gene structure.</b>
<i>KCNQ1</i> spans approximately 400 kb. The predominant isoform (isoform 1, refseq <a href="/nuccore/NM_000218" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000218.2</a>) consists of 16 exons and produces a protein of 676 amino acids. Other <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> encode a protein with an alternative N terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (isoform 2) or non-coding transcripts.</p><p><b>Pathogenic variants.</b> More than 500 pathogenic variants of <i>KCNQ1</i> have been reported, including pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and frameshift variants as well as large multiexon deletions.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The potassium voltage-gated channel subfamily KQT member 1 is the alpha subunit forming the slowly activating potassium delayed rectifier I<sub>Ks</sub> [<a class="bk_pop" href="#rws.REF.keating.2001.569">Keating &#x00026; Sanguinetti 2001</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> I<sub>Ks</sub> channel with reduced function</p></div><div id="rws.KCNH2"><h4><i>KCNH2</i></h4><p><b>Gene structure.</b>
<i>KCNH2</i> spans approximately 19 kb. The longest isoform consists of 16 exons and produces a protein of 1,159 amino acids (<a href="/nuccore/NM_000238" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000238.3</a>). Two shorter <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of <i>KCNH2</i> exist.</p><p><b>Pathogenic variants.</b> More than 700 pathogenic variants have been reported, including pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and frameshift variants as well as large multiexon deletions.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The potassium voltage-gated channel subfamily H member 2 is the alpha subunit forming the rapidly activating potassium delayed rectifier I<sub>Kr</sub>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> I<sub>Kr</sub> channel with reduced function</p></div><div id="rws.SCN5A"><h4><i>SCN5A</i></h4><p><b>Gene structure.</b>
<i>SCN5A</i> consists of 28 exons, spans approximately 80 kb; it encodes a protein of 2,016 amino acids (<a href="/nuccore/NM_198056.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_198056.2</a>). An isoform lacking amino acid Gln1077 exists.</p><p><b>Pathogenic variants.</b> More than 200 pathogenic variants are known; they include pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions or insertions.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The sodium channel protein type V alpha subunit is the alpha subunit forming the cardiac sodium channel.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variant resulting in a cardiac sodium channel with increased persistent inward current</p><p>For information on the genes listed in <a class="figpopup" href="/books/NBK1129/table/rws.T.molecular_genetics_of_lqts_less_co/?report=objectonly" target="object" rid-figpopup="figrwsTmoleculargeneticsoflqtslessco" rid-ob="figobrwsTmoleculargeneticsoflqtslessco">Table 2b</a>, click <a href="/books/NBK1129/bin/rws-less_common_genes.pdf">here</a> (pdf).</p></div></div></div><div id="rws.References"><h2 id="_rws_References_">References</h2><div id="rws.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rws.REF1">American College of Cardiology/American Heart Association Task Force, and the European Society of Cardiology/Committee for Practice Guidelines. Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Available <a href="http://circ.ahajournals.org/content/114/10/1088.full.pdf+html" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2006. Accessed 10-23-19. [<a href="/pubmed/16935995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16935995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vincent.2001">Vincent GM. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome. Heart. 86:12-4. Available <a href="/pmc/articles/PMC1729812/pdf/v086p00012.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2001. Accessed 10-23-19. [<a href="/pmc/articles/PMC1729812/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1729812</span></a>] [<a href="/pubmed/11410552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11410552</span></a>]</div></li></ul></div><div id="rws.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rws.REF.ackerman.2002.413">Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. <span><span class="ref-journal">Mayo Clin Proc. </span>2002;<span class="ref-vol">77</span>:413–21.</span> [<a href="/pubmed/12004990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12004990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.ackerman.2011.1308">Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). <span><span class="ref-journal">Heart Rhythm. </span>2011;<span class="ref-vol">8</span>:1308–39.</span> [<a href="/pubmed/21787999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21787999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.ackerman.2001.2264">Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. <span><span class="ref-journal">JAMA. </span>2001;<span class="ref-vol">286</span>:2264–9.</span> [<a href="/pubmed/11710892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11710892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.alexander.2004.72">Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2004;2004;<span class="ref-vol">15</span>:72–6.</span> [<a href="/pubmed/15028076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15028076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.arnestad.2007.361">Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. <span><span class="ref-journal">Circulation. </span>2007;<span class="ref-vol">115</span>:361–7.</span> [<a href="/pubmed/17210839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17210839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.barc.2011.40">Barc J, Briec F, Schmitt S, Kyndt F, Le Cunff M, Baron E, Vieyres C, Sacher F, Redon R, Le Caignec C, Le Marec H, Probst V, Schott JJ. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. <span><span class="ref-journal">J Am Coll Cardiol. </span>2011;<span class="ref-vol">57</span>:40–7.</span> [<a href="/pubmed/21185499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21185499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.chen.2007.20990">Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:20990–5.</span> [<a href="/pmc/articles/PMC2409254/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2409254</span></a>] [<a href="/pubmed/18093912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18093912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.chockalingam.2012.2092">Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, van der Heijden JF, Hauer RN, Beckmann BM, Spazzolini C, Rordorf R, Rydberg A, Clur SA, Fischer M, van den Heuvel F, K&#x000e4;&#x000e4;b S, Blom NA, Ackerman MJ, Schwartz PJ, Wilde AA. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. <span><span class="ref-journal">J Am Coll Cardiol. </span>2012;<span class="ref-vol">60</span>:2092–9.</span> [<a href="/pmc/articles/PMC3515779/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3515779</span></a>] [<a href="/pubmed/23083782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23083782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.cronk.2007.161">Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. <span><span class="ref-journal">Heart Rhythm. </span>2007;<span class="ref-vol">4</span>:161–6.</span> [<a href="/pmc/articles/PMC2836535/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2836535</span></a>] [<a href="/pubmed/17275750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17275750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.crotti.2013.1009">Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, K&#x000e4;&#x000e4;b S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL Jr. Calmodulin mutations associated with recurrent cardiac arrest in infants. <span><span class="ref-journal">Circulation. </span>2013;<span class="ref-vol">127</span>:1009–17.</span> [<a href="/pmc/articles/PMC3834768/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3834768</span></a>] [<a href="/pubmed/23388215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23388215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.giudicessi.2013.417">Giudicessi JR, Ackerman MJ. Genotype- and phenotype-guided management of congenital long QT syndrome. <span><span class="ref-journal">Curr Probl Cardiol. </span>2013;<span class="ref-vol">38</span>:417–55.</span> [<a href="/pmc/articles/PMC3940076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3940076</span></a>] [<a href="/pubmed/24093767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24093767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.goldenberg.2011.51">Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. <span><span class="ref-journal">J Am Coll Cardiol. </span>2011;<span class="ref-vol">57</span>:51–9.</span> [<a href="/pmc/articles/PMC3332533/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3332533</span></a>] [<a href="/pubmed/21185501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21185501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.goldenberg.2008.629">Goldenberg I, Zareba W, Moss AJ. Long QT syndrome. <span><span class="ref-journal">Curr Probl Cardiol. </span>2008;<span class="ref-vol">33</span>:629–94.</span> [<a href="/pubmed/18835466" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18835466</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.horner.2011.1698">Horner JM, Horner MM., Ackermann MJ. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. <span><span class="ref-journal">Heart Rhythm. </span>2011;<span class="ref-vol">8</span>:1698–704.</span> [<a href="/pubmed/21699858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21699858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.itoh.2010.1411">Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, Makiyama T, Akao M, Ai T, Noda T, Miyazaki A, Miyamoto Y, Yamagishi M, Kamakura S, Horie M. Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. <span><span class="ref-journal">Heart Rhythm. </span>2010;<span class="ref-vol">7</span>:1411–8.</span> [<a href="/pubmed/20541041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20541041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.jervell.1957.59">Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. <span><span class="ref-journal">Am Heart J. </span>1957;<span class="ref-vol">54</span>:59–68.</span> [<a href="/pubmed/13435203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13435203</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.johnson.2012.764">Johnson JN, Ackerman MJ. Competitive sports participation in athletes with congenital long QT syndrome. <span><span class="ref-journal">JAMA. </span>2012;<span class="ref-vol">308</span>:764–5.</span> [<a href="/pubmed/22820673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22820673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.jons.2010.783">Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W, Qi M, Robinson JL. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. <span><span class="ref-journal">J Am Coll Cardiol. </span>2010;<span class="ref-vol">55</span>:783–8.</span> [<a href="/pubmed/20170817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20170817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.kapplinger.2009.1297">Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. <span><span class="ref-journal">Heart Rhythm. </span>2009;<span class="ref-vol">6</span>:1297–303.</span> [<a href="/pmc/articles/PMC3049907/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3049907</span></a>] [<a href="/pubmed/19716085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19716085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.kaufman.2008.831">Kaufman ES, McNitt S, Moss AJ, Zareba W, Robinson JL, Hall WJ, Ackerman MJ, Benhorin J, Locati ET, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk of death in the long QT syndrome when a sibling has died. <span><span class="ref-journal">Heart Rhythm. </span>2008;<span class="ref-vol">5</span>:831–6.</span> [<a href="/pmc/articles/PMC2486317/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2486317</span></a>] [<a href="/pubmed/18534367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18534367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.keating.2001.569">Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. <span><span class="ref-journal">Cell. </span>2001;<span class="ref-vol">104</span>:569–80.</span> [<a href="/pubmed/11239413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11239413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.kimura.2012.344">Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y, Zang WJ, Ito M, Matsuura H, Horie M. Phenotype variability in patients carrying KCNJ2 mutations. <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2012;<span class="ref-vol">5</span>:344–53.</span> [<a href="/pubmed/22589293" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22589293</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.lieve.2015.ii1">Lieve KV, Wilde AA. Inherited ion channel diseases: a brief review. <span><span class="ref-journal">Europace. </span>2015;<span class="ref-vol">17</span> Suppl 2:ii1–ii6.</span> [<a href="/pubmed/26842110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26842110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.lieve.2013.553">Lieve KV, Williams L, Daly A, Richard G, Bale S, Macaya D, Chung WK. Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a clinical laboratory. <span><span class="ref-journal">Genet Test Mol Biomarkers. </span>2013;<span class="ref-vol">17</span>:553–61.</span> [<a href="/pubmed/23631430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23631430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.locati.1998.2237">Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. <span><span class="ref-journal">Circulation. </span>1998;<span class="ref-vol">97</span>:2237–44.</span> [<a href="/pubmed/9631873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9631873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.mohler.2007.432">Mohler PJ, Le Scouarnec S, Denjoy I, Lowe JS, Guicheney P, Caron L, Driskell IM, Schott JJ, Norris K, Leenhardt A, Kim RB, Escande D, Roden DM. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. <span><span class="ref-journal">Circulation. </span>2007;<span class="ref-vol">115</span>:432–41.</span> [<a href="/pubmed/17242276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17242276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.mohler.2003.634">Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. <span><span class="ref-journal">Nature. </span>2003;<span class="ref-vol">421</span>:634–9.</span> [<a href="/pubmed/12571597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12571597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.moss.2000.616">Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. <span><span class="ref-journal">Circulation. </span>2000;<span class="ref-vol">101</span>:616–23.</span> [<a href="/pubmed/10673253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10673253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.nannenberg.2012.183">Nannenberg EA, Sijbrands EJ, Dijksman LM, Alders M, van Tintelen JP, Birnie M, Van Langen IM, Wilde AA. Mortality of inherited arrhythmia syndromes: insight into their natural history. <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2012;<span class="ref-vol">5</span>:183–9.</span> [<a href="/pubmed/22373669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22373669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.priest.2016.11555">Priest JR, Gawad C, Kahlig KM, Yu JK, O'Hara T, Boyle PM, Rajamani S, Clark MJ, Garcia ST, Ceresnak S, Harris J, Boyle S, Dewey FE, Malloy-Walton L, Dunn K, Grove M, Perez MV, Neff NF, Chen R, Maeda K, Dubin A, Belardinelli L, West J, Antolik C, Macaya D, Quertermous T, Trayanova NA, Quake SR, Ashley EA. Early somatic mosaicism is a rare cause of long-QT syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2016;<span class="ref-vol">113</span>:11555–60.</span> [<a href="/pmc/articles/PMC5068256/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5068256</span></a>] [<a href="/pubmed/27681629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27681629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.priori.2004.1341">Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. <span><span class="ref-journal">JAMA. </span>2004;<span class="ref-vol">292</span>:1341–4.</span> [<a href="/pubmed/15367556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15367556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.priori.2003.1866">Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratification in the long-QT syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1866–74.</span> [<a href="/pubmed/12736279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12736279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.priori.2013.1932">Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. <span><span class="ref-journal">Heart Rhythm. </span>2013;<span class="ref-vol">10</span>:1932–63.</span> [<a href="/pubmed/24011539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24011539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2011.2181">Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. <span><span class="ref-journal">Circulation. </span>2011;<span class="ref-vol">124</span>:2181–4.</span> [<a href="/pubmed/22083145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22083145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2012.868">Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. <span><span class="ref-journal">Circ Arrhythm Electrophysiol. </span>2012;<span class="ref-vol">5</span>:868–877.</span> [<a href="/pmc/articles/PMC3461497/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3461497</span></a>] [<a href="/pubmed/22895603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22895603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.1993.782">Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. <span><span class="ref-journal">Circulation. </span>1993;<span class="ref-vol">88</span>:782–4.</span> [<a href="/pubmed/8339437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8339437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2004.1826">Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:1826–33.</span> [<a href="/pubmed/15051644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15051644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2003.1120">Schwartz PJ, Priori SG, Napolitano C. How really rare are rare diseases? <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2003;<span class="ref-vol">14</span>:1120–1.</span> [<a href="/pubmed/14521668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14521668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2001.89">Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. <span><span class="ref-journal">Circulation. </span>2001;<span class="ref-vol">103</span>:89–95.</span> [<a href="/pubmed/11136691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11136691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.schwartz.2009.113">Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false? <span><span class="ref-journal">Heart Rhythm. </span>2009;<span class="ref-vol">6</span>:113–20.</span> [<a href="/pubmed/19121811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19121811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.seth.2007.1092">Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome and pregnancy. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007;<span class="ref-vol">49</span>:1092–8.</span> [<a href="/pubmed/17349890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17349890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.shigemizu.2015.e0130329">Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, Toda T, Miyamoto Y, Fujimoto A, Suzuki Y, Kubo M, Tsunoda T, Shimizu W, Tanaka T. Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>:e0130329.</span> [<a href="/pmc/articles/PMC4488844/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4488844</span></a>] [<a href="/pubmed/26132555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26132555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.shimizu.2004.276">Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. <span><span class="ref-journal">Heart Rhythm. </span>2004;<span class="ref-vol">1</span>:276–83.</span> [<a href="/pubmed/15851169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15851169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.spazzolini.2009.832">Spazzolini C, Mullally J, Moss AJ, Schwartz PJ, McNitt S, Ouellet G, Fugate T, Goldenberg I, Jons C, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Crotti L, Kaufman ES, Locati EH, Qi M, Napolitano C, Priori SG, Towbin JA, Vincent GM. Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. <span><span class="ref-journal">J Am Coll Cardiol. </span>2009;<span class="ref-vol">54</span>:832–7.</span> [<a href="/pmc/articles/PMC3517782/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3517782</span></a>] [<a href="/pubmed/19695463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19695463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.swan.1998.508">Swan H, Toivonen L, Viitasalo M. Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. <span><span class="ref-journal">Eur Heart J. </span>1998;<span class="ref-vol">19</span>:508–13.</span> [<a href="/pubmed/9568456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9568456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.sy.2011.2187">Sy RW, van der Werf C, Chattha IS, Chockalingam P, Adler A, Healey JS, Perrin M, Gollob MH, Skanes AC, Yee R, Gula LJ, Leong-Sit P, Viskin S, Klein GJ, Wilde AA, Krahn AD. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. <span><span class="ref-journal">Circulation. </span>2011;<span class="ref-vol">124</span>:2187–94.</span> [<a href="/pubmed/22042885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22042885</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.tester.2005.507">Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. <span><span class="ref-journal">Heart Rhythm. </span>2005;<span class="ref-vol">2</span>:507–17.</span> [<a href="/pubmed/15840476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15840476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.van_langen.2003.141">Van Langen IM, Birnie E, Alders M, Jongbloed RJ, Le Marec H, Wilde AA. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:141–5.</span> [<a href="/pmc/articles/PMC1735373/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735373</span></a>] [<a href="/pubmed/12566525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12566525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vatta.2006.2104">Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">114</span>:2104–12.</span> [<a href="/pubmed/17060380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17060380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vincent.1991.498">Vincent GM, Jaiswal D, Timothy KW. Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. <span><span class="ref-journal">Am J Cardiol. </span>1991;<span class="ref-vol">68</span>:498–503.</span> [<a href="/pubmed/1872278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1872278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vincent.2009.215">Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, Crotti L, Piippo K, Lupoglazoff JM, Villain E, Priori SG, Napolitano C, Zhang L. High efficacy of beta-blockers in long-QT syndrome type1; contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures". <span><span class="ref-journal">Circulation. </span>2009;<span class="ref-vol">119</span>:215–21.</span> [<a href="/pubmed/19118258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19118258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vincent.1992.846">Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. <span><span class="ref-journal">N Engl J Med. </span>1992;<span class="ref-vol">327</span>:846–52.</span> [<a href="/pubmed/1508244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1508244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.viskin.2010.1955">Viskin S, Postema PG, Bhuiyan ZA, Rosso R, Kalman JM, Vohra JK, Guevara-Valdivia ME, Marquez MF, Kogan E, Belhassen B, Glikson M, Strasberg B, Antzelevitch C, Wilde AAM. The response of the QT interval to the brief tachycardia provoked by standing a bedside test for diagnosing long QT syndrome. <span><span class="ref-journal">JACC. </span>2010;<span class="ref-vol">55</span>:1955–61.</span> [<a href="/pmc/articles/PMC2862092/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2862092</span></a>] [<a href="/pubmed/20116193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20116193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.vyas.2006.1385">Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">113</span>:1385–92.</span> [<a href="/pubmed/16534005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16534005</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.wedekind.2006.129">Wedekind H, Bajanowski T, Friederich P, Breithardt G, W&#x000fc;lfing T, Siebrands C, Engeland B, M&#x000f6;nnig G, Haverkamp W, Brinkmann B, Schulze-Bahr E. Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study. <span><span class="ref-journal">Int J Legal Med. </span>2006;<span class="ref-vol">120</span>:129–37.</span> [<a href="/pubmed/16012827" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16012827</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.westenskow.2004.1834">Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC. Compound mutations: a common cause of severe long-QT syndrome. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:1834–41.</span> [<a href="/pubmed/15051636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15051636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.yang.2010.872">Yang Y, Yang Y, Liang B, Liu J, Li J, Grunnet M, Olesen SP, Rasmussen HB, Ellinor PT, Gao L, Lin X, Li L, Wang L, Xiao J, Liu Y, Liu Y, Zhang S, Liang D, Peng L, Jespersen T, Chen YH. Identification of a Kir3.4 mutation in congenital long QT syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:872–80.</span> [<a href="/pmc/articles/PMC3032079/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3032079</span></a>] [<a href="/pubmed/20560207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20560207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.zareba.2003.337">Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. <span><span class="ref-journal">J Cardiovasc Electrophysiol. </span>2003;<span class="ref-vol">14</span>:337–41.</span> [<a href="/pubmed/12741701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12741701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.zareba.1998.960">Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">339</span>:960–5.</span> [<a href="/pubmed/9753711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9753711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rws.REF.zhang.2000.2849">Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. <span><span class="ref-journal">Circulation. </span>2000;<span class="ref-vol">102</span>:2849–55.</span> [<a href="/pubmed/11104743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11104743</span></a>]</div></li></ul></div></div><div id="rws.Chapter_Notes"><h2 id="_rws_Chapter_Notes_">Chapter Notes</h2><div id="rws.Author_History"><h3>Author History</h3><p>Mari&#x000eb;lle Alders, PhD (2012-present)<br />Hennie Bikker, PhD (2018-present)<br />Imke Christiaans, PhD, MD (2015-present)<br />Marcel MAM Mannens, PhD; University of Amsterdam (2012-2015)<br />G Michael Vincent, MD; University of Utah School of Medicine (2003-2012)</p></div><div id="rws.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>8 February 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 June 2015 (me) Comprehensive update posted live (title change)</div></li><li class="half_rhythm"><div>31 May 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 August 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available for LQT1, LQT2, LQT3, LQT5, LQT6</div></li><li class="half_rhythm"><div>7 May 2009 (gmv) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically for LQT2 and LQT3; additions to Management</div></li><li class="half_rhythm"><div>21 May 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 July 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 February 2005 (gmv) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> clinically available; LQt4 moved to Differential Diagnosis</div></li><li class="half_rhythm"><div>13 April 2004 (cd) Revision: <i>ANK2</i> testing clinically available</div></li><li class="half_rhythm"><div>11 February 2004 (bp/gmv) Revisions</div></li><li class="half_rhythm"><div>18 November 2003 (gmv) Revisions</div></li><li class="half_rhythm"><div>16 June 2003 (gmv) Revision: Table 4</div></li><li class="half_rhythm"><div>20 February 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>25 October 2002 (gmv) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1129</span><span class="label">PMID: <a href="/pubmed/20301308" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301308</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/loeys-dietz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lowe/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1129&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1129/?report=reader">PubReader</a></li><li><a href="/books/NBK1129/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1129" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1129" style="display:none" title="Cite this Page"><div class="bk_tt">Alders M, Bikker H, Christiaans I. Long QT Syndrome. 2003 Feb 20 [Updated 2018 Feb 8]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1129/pdf/Bookshelf_NBK1129.pdf">PDF version of this page</a> (530K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#rws.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#rws.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#rws.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#rws.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#rws.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#rws.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#rws.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#rws.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#rws.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#rws.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#rws.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10142[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AKAP9</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6331[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCN5A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3753[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNE1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3759[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNJ2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=287[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ANK2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=801[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CALM1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3784[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=859[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CAV3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3757[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNH2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9992[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNE2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=805[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CALM2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6640[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SNTA1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3762[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNJ5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=775[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CACNA1C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6330[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCN4B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9469[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHST3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=144245[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG10B</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479730" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479730" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479730" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479730" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301579" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Jervell and Lange-Nielsen Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Jervell and Lange-Nielsen Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjærg L, Samson RA, Green GE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301466" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Catecholaminergic Polymorphic Ventricular Tachycardia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Napolitano C, Priori SG, Bloise R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301441" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Andersen-Tawil Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Andersen-Tawil Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Veerapandiyan A, Statland JM, Tawil R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18606002" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital long QT syndrome.</a><span class="source">[Orphanet J Rare Dis. 2008]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital long QT syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Crotti L, Celano G, Dagradi F, Schwartz PJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2008 Jul 7; 3:18. Epub 2008 Jul 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16831322" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].</a><span class="source">[Zhonghua Nei Ke Za Zhi. 2006]</span><div class="brieflinkpop offscreen_noflow">[Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu WL, Hu DY, Li P, Li CL, Qin XG, Li YT, Li L, Li ZM, Dong W, Qi Y, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Zhonghua Nei Ke Za Zhi. 2006 Jun; 45(6):463-6. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301308" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301308" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9335dd21425a25c7c114">Long QT Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Long QT Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:24:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88434BDFC837910000000007950362&amp;ncbi_session=CE88434BDFC93351_1941SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1129%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1129&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1129/&amp;ncbi_pagename=Long QT Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88434BDFC93351_1941SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>